ZnT8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onset.
Vaziri-Sani
Fariba
F
Department of Clinical Sciences, University Hospital MAS, Lund University, Malmö, Sweden.
Oak
Shilpa
S
Radtke
Jared
J
Lernmark
Ke
K
Lynch
Kristian
K
Agardh
Carl-D
CD
Cilio
Corrado M
CM
Lethagen
Asa L
AL
Ortqvist
Eva
E
Landin-Olsson
Mona
M
Törn
Carina
C
Hampe
Christiane S
CS
D000293:Adolescent; D000328:Adult; D017668:Age of Onset; D001323:Autoantibodies / Q000097:blood / Q000276:immunology*; D027682:Cation Transport Proteins / Q000276:immunology*; D002648:Child; D015331:Cohort Studies; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology*; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D020033:Protein Isoforms / Q000276:immunology; D011869:Radioligand Assay; D018709:Statistics, Nonparametric; D055815:Young Adult; D000075703:Zinc Transporter 8
D001323:Autoantibodies; D027682:Cation Transport Proteins; D020033:Protein Isoforms; C492522:SLC30A8 protein, human; D000075703:Zinc Transporter 8